These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33287911)

  • 1. Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial.
    Sakr Y; Bauer M; Nierhaus A; Kluge S; Schumacher U; Putensen C; Fichtner F; Petros S; Scheer C; Jaschinski U; Tanev I; Jacob D; Weiler N; Schulze PC; Fiedler F; Kapfer B; Brunkhorst F; Lautenschlaeger I; Wartenberg K; Utzolino S; Briegel J; Moerer O; Bischoff P; Zarbock A; Quintel M; Gattinoni L;
    Trials; 2020 Dec; 21(1):1002. PubMed ID: 33287911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial.
    Parker MJ; Thabane L; Fox-Robichaud A; Liaw P; Choong K;
    Trials; 2016 Nov; 17(1):556. PubMed ID: 27876084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial-study protocol for a randomized controlled trial.
    Legrand M; Oufella HA; De Backer D; Duranteau J; Leone M; Levy B; Rossignol P; Vicaut E; Dépret F;
    Trials; 2020 Jul; 21(1):601. PubMed ID: 32611377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsis.
    Marx G; Zacharowski K; Ichai C; Asehnoune K; Černý V; Dembinski R; Ferrer Roca R; Fries D; Molnar Z; Rosenberger P; Sanchez-Sanchez M; Schürholz T; Dehnhardt T; Schmier S; von Kleist E; Brauer U; Simon TP
    Trials; 2021 Jun; 22(1):376. PubMed ID: 34078421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of different crystalloids on internal environment in patients with septic shock receiving early fluid resuscitation: a prospective randomized controlled trial].
    Wang X; Yuan Z; Chen Q; Yu J; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Sep; 30(9):824-829. PubMed ID: 30309406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial.
    Weiss SL; Balamuth F; Long E; Thompson GC; Hayes KL; Katcoff H; Cook M; Tsemberis E; Hickey CP; Williams A; Williamson-Urquhart S; Borland ML; Dalziel SR; Gelbart B; Freedman SB; Babl FE; Huang J; Kuppermann N;
    Trials; 2021 Nov; 22(1):776. PubMed ID: 34742327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin replacement in patients with severe sepsis or septic shock.
    Caironi P; Tognoni G; Masson S; Fumagalli R; Pesenti A; Romero M; Fanizza C; Caspani L; Faenza S; Grasselli G; Iapichino G; Antonelli M; Parrini V; Fiore G; Latini R; Gattinoni L;
    N Engl J Med; 2014 Apr; 370(15):1412-21. PubMed ID: 24635772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
    Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
    Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial fluid resuscitation (30 mL/kg) in patients with septic shock: More or less?
    Wang HL; Shao J; Liu WL; Wu F; Chen HB; Zheng RQ; Chen QH
    Am J Emerg Med; 2021 Dec; 50():309-315. PubMed ID: 34428728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septic shock-3 vs 2: an analysis of the ALBIOS study.
    Vasques F; Duscio E; Romitti F; Pasticci I; Caironi P; Meessen J; Latini R; Cressoni M; Camporota L; Pesenti A; Fumagalli R; Quintel M; Gattinoni L
    Crit Care; 2018 Sep; 22(1):237. PubMed ID: 30261898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.
    Dellinger RP; Levy MM; Rhodes A; Annane D; Gerlach H; Opal SM; Sevransky JE; Sprung CL; Douglas IS; Jaeschke R; Osborn TM; Nunnally ME; Townsend SR; Reinhart K; Kleinpell RM; Angus DC; Deutschman CS; Machado FR; Rubenfeld GD; Webb S; Beale RJ; Vincent JL; Moreno R;
    Intensive Care Med; 2013 Feb; 39(2):165-228. PubMed ID: 23361625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, double-blind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial.
    Hwang SY; Park JE; Jo IJ; Kim S; Chung SP; Kong T; Shin J; Lee HJ; You KM; Jo YH; Kim D; Suh GJ; Kim T; Kim WY; Kim YJ; Ryoo SM; Choi SH; Shin TG;
    Trials; 2019 Jul; 20(1):420. PubMed ID: 31296251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REstricted Fluid REsuscitation in Sepsis-associated Hypotension (REFRESH): study protocol for a pilot randomised controlled trial.
    Macdonald SPJ; Taylor DM; Keijzers G; Arendts G; Fatovich DM; Kinnear FB; Brown SGA; Bellomo R; Burrows S; Fraser JF; Litton E; Ascencio-Lane JC; Anstey M; McCutcheon D; Smart L; Vlad I; Winearls J; Wibrow B
    Trials; 2017 Aug; 18(1):399. PubMed ID: 28851407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of albumin and crystalloid on mortality in adult patients with severe sepsis and septic shock: a meta-analysis of randomized clinical trials.
    Xu JY; Chen QH; Xie JF; Pan C; Liu SQ; Huang LW; Yang CS; Liu L; Huang YZ; Guo FM; Yang Y; Qiu HB
    Crit Care; 2014 Dec; 18(6):702. PubMed ID: 25499187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
    Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
    Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin administration in septic shock-Protocol for post-hoc analyses of data from a multicentre RCT.
    Meyhoff TS; Granholm A; Hjortrup PB; Sivapalan P; Lange T; Laake JH; Cronhjort M; Jakob SM; Cecconi M; Nalos M; Ostermann M; Malbrain MLNG; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2023 Sep; 67(8):1128-1136. PubMed ID: 37246841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin replacement therapy in immunocompromised patients with sepsis - Secondary analysis of the ALBIOS trial.
    Cortegiani A; Grasselli G; Meessen J; Moscarelli A; Ippolito M; Turvani F; Bonenti CM; Romagnoli S; Volta CA; Bellani G; Giarratano A; Latini R; Pesenti A; Caironi P
    J Crit Care; 2021 Jun; 63():83-91. PubMed ID: 33636427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.
    Dellinger RP; Levy MM; Carlet JM; Bion J; Parker MM; Jaeschke R; Reinhart K; Angus DC; Brun-Buisson C; Beale R; Calandra T; Dhainaut JF; Gerlach H; Harvey M; Marini JJ; Marshall J; Ranieri M; Ramsay G; Sevransky J; Thompson BT; Townsend S; Vender JS; Zimmerman JL; Vincent JL; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Crit Care Med; 2008 Jan; 36(1):296-327. PubMed ID: 18158437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.